Autopsy report · NCT02274506

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

“PI's response to ePAAC, has withdrawn the protocol acknowledging the PI's action.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Blood And Marrow Transplantation; Leukemia; Lymphoma

Interventions

Cyclophosphamide; Fludarabine; T-Cell Infusion

Participants

0

Trials that died the same way

• EXCOR® Pediatric VAD Anticoagulation IDE
  “PI withdrew protocol” (69% match in meaning)
• Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
  “withdrawn by the PI” (59% match in meaning)
• RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
  “Protocol was withdrawn from IND” (59% match in meaning)
• Effect of Perioperative Intravenous Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery
  “Withdrawn by PI” (59% match in meaning)
• Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior
  “PI withdrawn” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.